Financials
- Market Capitalization 14.97 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-20.24
売上高対価格比率
29.18
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 682 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 244.54 USD | -2.61% | -3.00% | -4.03% | +74.67% | 15.87 B USD | ||
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 247.91 USD | -0.58% | -3.29% | -0.84% | +20.88% | 15.36 B USD | ||
| 760 | EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | -0.82% | +39.47% | 13.49 B USD | ||
| 799 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +6.72% | +10.74% | 12.52 B USD |